Online Educational Tools (August 2009)
NICE publishes first menu of potential indicators for 2010/11 QOF (10th August 2009)
On 10 August the National Institute for Health and Clinical Excellence (NICE) published the first menu of potential indicators for the 2010/11 Quality and Outcomes Framework (QOF) together with recommendations on indicators to be considered for retirement.
QOF Indicators
In collaboration with BMJ Learning, NICE offers a series of free educational modules suitable for all clinical staff in the healthcare team, as well as doctors. You do not have to be a BMA member or a BMJ subscriber.
Tools
Tools
NICE publishes first menu of potential indicators for 2010/11 QOF (10th August 2009)
On 10 August the National Institute for Health and Clinical Excellence (NICE) published the first menu of potential indicators for the 2010/11 Quality and Outcomes Framework (QOF) together with recommendations on indicators to be considered for retirement.
QOF Indicators
Lung cancer (non-small-cell, first line treatment) - pemetrexed: final appraisal determination (6th August 2009)
After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination (FAD) on Lung cancer (non-small-cell, first line treatment) - pemetrexedand submitted it to the Institute.
The FAD has been sent to the formal consultees for this appraisal who have 15 working days to consider whether they wish to appeal against it. Subject to any appeal by consultees, the FAD may be used as the basis for the Institute's guidance on the use of the appraised technology in the NHS in England and Wales.
Closing date of the appeal is 21st August 2009.
FAD
After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination (FAD) on Lung cancer (non-small-cell, first line treatment) - pemetrexedand submitted it to the Institute.
The FAD has been sent to the formal consultees for this appraisal who have 15 working days to consider whether they wish to appeal against it. Subject to any appeal by consultees, the FAD may be used as the basis for the Institute's guidance on the use of the appraised technology in the NHS in England and Wales.
Closing date of the appeal is 21st August 2009.
FAD
Self-harm (longer term management): scope consultation (7th August 2009)
NICE have been asked to develop a clinical practice guideline on Self-harm (longer term management) for use in the NHS in England, Wales and Northern Ireland. The draft scope defines what aspects of care the guideline will cover and to whom it will apply. Registered stakeholders for the Self-harm (longer term management) guideline are invited to submit comments on the scope and may suggest clinical questions that could be answered in the guideline.
Closing date for comments is 4th September 2009.
Consultation
NICE have been asked to develop a clinical practice guideline on Self-harm (longer term management) for use in the NHS in England, Wales and Northern Ireland. The draft scope defines what aspects of care the guideline will cover and to whom it will apply. Registered stakeholders for the Self-harm (longer term management) guideline are invited to submit comments on the scope and may suggest clinical questions that could be answered in the guideline.
Closing date for comments is 4th September 2009.
Consultation
Latest Implementation Tools (12th August 2009)
Tools to aid implementation of recently published NICE guidance.
Tools to aid implementation of recently published NICE guidance.
When to suspect child maltreatment: Costing Statement
Low back pain: Audit Support and Commissioning Fact Sheet
Diabetes Type 2 (new drugs) update: Audit Support - Organisational Criteria and Audit Support - Clinical Criteria
Coeliac Disease: Audit Support, Commissioning Factsheet and Guide to Resources
Hepatitis B - Tenofovir Disoproxil Fumarate: Audit Support and Costing Tools
Leukaemia (Chronic Lymphocystic, first line) - Rituximab: Audit Support and Costing Tools
Image-guided Radiofrequency Excision Biopsy of Breast Lesion: Audit Support
Sinus Tarsi Implant Insertion for Mobile Flatfoot: Audit Support
No comments:
Post a Comment